Washington Trust’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
OAG
PCM
Washington Trust's CELG Position: Q1 2019 in Review
Washington Trust sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 100,153 shares — an estimated $6.42M sold.
Washington Trust first reported a position in CELG in Q1 2014 and held it in 20 quarters. The position peaked at $19.6M in Q3 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.
- Washington Trust reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
- Washington Trust sold 100,153 Celgene Corp shares in Q1 2019, an estimated $6.42M.
- Washington Trust first reported a position in Celgene Corp in Q1 2014 and held it in 20 quarters.
- Washington Trust's Celgene Corp position peaked at $19.6M in Q3 2017.
- 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.
Based on Washington Trust's 13F filing for Q1 2019, filed 13 May 2019.